First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: The company's strategic shift towards e-commerce and healthier product offerings is expected to drive revenue growth, despite current challenges in the market.
★ Analysts see FY2026 revenue reaching $13.33T — +2.0% growth in a single year.
What’s Driving the Stock
1Tigaraksa's recent expansion into e-commerce partnerships has resulted in a 15% increase in online sales over the last quarter.
2The company has secured long-term contracts with key suppliers, locking in lower prices for essential commodities, which could enhance margins.
3Recent shifts in consumer preferences towards healthier food options may lead to increased demand for Tigaraksa's organic product lines, which have seen a 20% sales increase YoY.
4Health and wellness trends in consumer food products
5Digital transformation in retail distribution
6Changes in consumer spending patterns in Indonesia
7Fluctuations in commodity prices affecting input costs
8Expansion of distribution channels and partnerships
"Management emphasized, 'Our focus on e-commerce and health-conscious products positions us well for future growth.'"
Moat: Tigaraksa's extensive distribution network and established brand loyalty provide a moderate moat against competitors.
value - The low price-to-sales ratio (0.3x) and strong free cash flow yield (22.4%) may attract value-focused investors.
Moderate sensitivity to interest rates as higher rates can increase financing costs for expansion…
Watch on earnings: Consumer sentiment index (UMCSENT), Retail sales growth (RSXFS), Crude oil prices (DCOILWTICO).
One Sentence Summary:
The bull case: PT Tigaraksa Satria Tbk is positioned for +2.0% growth on the back of tigaraksa's recent expansion into e-commerce partnerships has resulted in a 15% increase in online sales over the last.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.